Compare ARK Genomic Revolution ETF (ARKG) vs NICE Ltd (NICE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs NICE Ltd — how do they compare? ARK Genomic Revolution ETF trades at $41.37, while NICE Ltd trades at $104.31 (market cap $5.87B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, NICE Ltd nearer its low. Which is the better fit depends on your goals.
| ARKG | NICE | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $170.37 |
52-Week Low | $23.09 | $83.15 |
Market Cap | — | $5.87B |
Enterprise Value | — | $5.65B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
NICE trades at $99.74, up 1.92% today, with a bullish technical signal and strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, with a P/E of 11.82 suggesting potential undervaluation. Recent news highlights expansion in AI-powered customer experience solutions, including partnerships and AWS integration, driving positive sentiment.
The outlook is positive with a consensus price target of $124.88, implying significant upside. Risks include competitive pressures in the software sector and potential margin compression as revenue growth moderates. Institutional ownership trends and bullish analyst ratings support a favorable investment case, though market volatility remains a concern.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About NICE Ltd
NICE Ltd. is a global leader in both enterprise software and cloud computing, specializing in customer experience and financial crime prevention solutions. The company's platform utilizes advanced analytics, AI, and automation to help organizations enhance customer interactions, ensure compliance, and combat fraud. NICE serves a diverse client base, including contact centers, financial institutions, and government agencies, by optimizing operations and improving service quality.
Read more on NICE →
